(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ: PACB) fell 8.64% to $5.24 at 13:55 EST on Wednesday, after two sequential sessions in a row of gains. NASDAQ is sliding 3.73% to $11,537.57, following the last session’s upward trend. This seems, so far, a very bearish trend exchanging session today.
Pacific Biosciences of California’s last close was $5.73, 84.24% under its 52-week high of $36.36.
Volume
Today’s last reported volume for Pacific Biosciences of California is 4536745 which is 27.45% below its average volume of 6253390.
Pacific Biosciences of California’s Sales
Pacific Biosciences of California’s sales growth is 33.8% for the present quarter and 48.3% for the next. The company’s growth estimates for the present quarter is a negative 178.4% and positive 40% for the next.
Pacific Biosciences of California’s Revenue
Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.
Volatility
Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a positive 5.68%, a negative 1.50%, and a positive 5.92%, respectively.
Pacific Biosciences of California’s highest amplitude of average volatility was 9.10% (last week), 6.43% (last month), and 5.92% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Pacific Biosciences of California’s stock is considered to be oversold (<=20).
Pacific Biosciences of California’s Stock Yearly Top and Bottom Value
Pacific Biosciences of California’s stock is valued at $5.24 at 13:55 EST, way under its 52-week high of $36.36 and way above its 52-week low of $4.51.
Pacific Biosciences of California’s Moving Average
Pacific Biosciences of California’s worth is way under its 50-day moving average of $8.33 and way below its 200-day moving average of $18.79.
More news about Pacific Biosciences of California (PACB).
